Stephens reissued their overweight rating on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a research report report published on Thursday, Benzinga reports. Stephens currently has a $24.00 price objective on the stock.
Other research analysts have also recently issued reports about the stock. Citigroup began coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set a buy rating and a $21.00 target price on the stock. Mizuho initiated coverage on Ardent Health Partners in a report on Monday, August 12th. They issued an outperform rating and a $20.00 price objective for the company. Morgan Stanley initiated coverage on Ardent Health Partners in a research report on Monday, August 12th. They set an overweight rating and a $27.00 target price for the company. Leerink Partnrs raised Ardent Health Partners to a strong-buy rating in a research note on Monday, August 12th. Finally, JPMorgan Chase & Co. began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a neutral rating and a $18.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of Buy and a consensus target price of $21.70.
Read Our Latest Report on ARDT
Ardent Health Partners Stock Up 1.7 %
Ardent Health Partners (NYSE:ARDT – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.05. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.46 billion. As a group, equities research analysts predict that Ardent Health Partners will post 1.25 earnings per share for the current fiscal year.
About Ardent Health Partners
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Read More
- Five stocks we like better than Ardent Health Partners
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is a Dividend King?
- MarketBeat Week in Review – 9/16 – 9/20
- Trading Halts Explained
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.